NeuroMetrix, Inc. to Present at Needham's Fifth Annual Biotechnology and Medical Technology Conference on Thursday, June 15th.

WALTHAM, Mass. -- NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at Needham's Fifth Annual Biotechnology and Medical Conference at the New York Palace Hotel in New York City at 3:30pm (EST) on Thursday, June 15th. The audio presentation will be simultaneously available via webcast on the "Investors" home page at http://www.neurometrix.com.

Shai Gozani, MD, PhD, NeuroMetrix Chief Executive Officer and President, will be presenting at the conference. Dr. Gozani will provide an overview of NeuroMetrix and will provide an update on operational and strategic matters relating to the business.

About NeuroMetrix

NeuroMetrix is a medical device company that is establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. The NC-stat System, the Company's neuropathy diagnostic system, has been on the market since May 1999 and is presently used in over 3,600 physician's offices and clinics in the United States. The Company holds issued utility patents covering a number of important aspects of the NC-stat System.